Browser-side verification
Verify Rifampicin (rifampin)
คุณไม่ต้องเชื่อ source.cuvetsmo.com — โค้ดด้านล่างทำงานในเครื่องของคุณ คำนวณ SHA-256 และ verify Ed25519 signature เทียบกับ public key ที่อาจารย์เซ็นต์รับเก็บไว้.
Signatures
0
Version
1
Status
pending
⏳ ยังไม่มี signature
Entry นี้ยังไม่ได้ลงนามโดย key ใดเลย — Phase 0 mirror snapshot ที่รอ Thai translation + faculty signoff. ดูสถานะการ review ที่ หน้า detail
Show the raw inputs (paranoid mode)
Drug JSON
This is exactly what your browser canonicalizes + SHA-256-hashes
{
"slug": "rifampicin",
"nameEn": "Rifampicin (rifampin)",
"nameTh": "ไรแฟมพิซิน (ไรแฟมพิน)",
"class": "Antimycobacterial / antibacterial (rifamycin)",
"mechanism": "ยับยั้ง DNA-dependent RNA polymerase ของแบคทีเรีย ฤทธิ์ฆ่าเชื้อ ซึมเข้าเซลล์/ฝีได้ดี ใช้กับ Rhodococcus และ staph ลึก — ต้องใช้ร่วมยาอื่นเสมอ (ดื้อยาเร็ว)",
"brandNamesTh": [
"Rifadin"
],
"indications": [
{
"text": "การติดเชื้อ Rhodococcus equi ในลูกม้า (ร่วม macrolide), staphylococcal pyoderma ลึก/granuloma (adjunct), และ mycobacterial infection — ใช้ร่วมยาอื่นเสมอ",
"cites": [
"dailymed-rifampin",
"plumbs"
]
}
],
"contraindications": [
{
"text": "⚠️ ห้ามใช้เดี่ยว (เกิดดื้อยาเร็วมาก); พิษต่อตับ (ติดตามเอนไซม์ตับ); เป็น enzyme inducer แรง (CYP450 — drug interaction มาก)",
"cites": [
"dailymed-rifampin",
"plumbs"
]
}
],
"sideEffects": [
{
"text": "พิษตับ, สารคัดหลั่ง/ปัสสาวะ/น้ำตาเป็นสีส้ม-แดง (ปกติ), คลื่นไส้/เบื่ออาหาร, drug interaction จากการเหนี่ยวนำเอนไซม์",
"cites": [
"plumbs",
"wikipedia-Rifampicin"
]
}
],
"dosages": [
{
"species": "equine",
"indication": "Rhodococcus equi (foal, with macrolide)",
"route": "PO",
"dose": "5–10 mg/kg PO ทุก 12–24 ชั่วโมง ร่วมกับ macrolide (เช่น clarithromycin/azithromycin)",
"cites": [
"plumbs",
"dailymed-rifampin"
]
},
{
"species": "canine",
"indication": "Deep staphylococcal pyoderma / granuloma (adjunct)",
"route": "PO",
"dose": "5–10 mg/kg PO ทุก 12–24 ชั่วโมง ร่วมยาปฏิชีวนะตัวอื่น — ติดตามตับ",
"cites": [
"plumbs"
]
}
],
"citations": [
{
"id": "atc-J04AB02",
"type": "regulatory-database",
"title": "WHO ATC/DDD Index — Rifampicin (rifampin) (J04AB02)",
"year": 2026,
"url": "https://www.whocc.no/atc_ddd_index/?code=J04AB02&showdescription=no",
"note": "WHO Anatomical Therapeutic Chemical classification. Authoritative for class + INN.",
"cid": null
},
{
"id": "dailymed-rifampin",
"type": "package-insert",
"title": "Rifampin — DailyMed (FDA label)",
"year": 2026,
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=rifampin",
"note": "FDA structured product label (human or veterinary). Authoritative for indications, contraindications, labeled use.",
"cid": null
},
{
"id": "plumbs",
"type": "textbook",
"title": "Plumb's Veterinary Drug Handbook, 10th Edition",
"authors": "Plumb DC",
"year": 2023,
"edition": "10th",
"url": "https://www.plumbs.com/",
"note": "Standard veterinary drug reference. Species doses cross-checked against this handbook.",
"cid": null
},
{
"id": "wikipedia-Rifampicin",
"type": "monograph",
"title": "Rifampicin — Wikipedia",
"year": 2026,
"url": "https://en.wikipedia.org/wiki/Rifampicin",
"note": "Tertiary cross-check for class + mechanism + ATC code. CC BY-SA 4.0. Not sole authority.",
"cid": null
}
],
"mirroredFrom": [
{
"id": "who-atc",
"name": "WHO ATC/DDD Index",
"url": "https://www.whocc.no/atc_ddd_index/",
"asOfDate": "2026-06-07",
"license": "WHO publication, free for use with attribution"
}
],
"mirrorCIDs": [],
"codes": {
"atc": {
"code": "J04AB02",
"name": "Rifampicin (rifampin)",
"level": 5
}
},
"drafting": {
"aiAssisted": false,
"aiModel": null,
"aiPromptHash": null,
"humanReviewer": "palmzamak2547",
"humanReviewedAt": "2026-06-07",
"humanEditsRatio": null
},
"signatures": [],
"reviewedBy": null,
"lastUpdated": "2026-06-07",
"version": 1,
"changelog": [
{
"version": 1,
"date": "2026-06-07",
"summary": "New entry — clinical content compiled from cited authoritative sources (WHO ATC / FDA label / Plumb’s), cross-checked. Every statement cited. Reviewed by palmzamak2547. Pending faculty canonical signature."
}
]
}Public keys used
[]